Kids splashed through muddy puddles in their rain boots, families stopped to smell the flowers, and friends posed for photos ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

AstraZeneca's booth is seen during an expo in Beijing in November. The pharma company announced an investment of $2.5 billion to establish a global R&D center in Beijing. CHINA DAILY Multinational ...

MOUNT VERNON, Wash. — Update: The 18-year-old was identified as Alan Noel Mora Gomez from Seattle. His family has created a GoFundMe to help lay him to rest. According to the family, Alan was a ...

Mt. Vernon's season ended with a 63-59 loss to Jeffersonville in Saturday's Class 4A semistate semifinal at New Castle. The Marauders knocked off No. 5 Anderson and No. 2 Greenfield-Central to win ...

Only show cars that can be delivered to me. Please enter your postal code in order to show cars that can be delivered to you.

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer (NSCLC), the British pharma has rolled out early data from a trial ...

Speaking to the Commons business and trade select committee on Tuesday, AstraZeneca’s chairman Shaun Grady confirmed that delays in securing a £90 million government contribution led to the collapse ...

Doorbell cameras are increasingly playing a role in crime prevention and investigations, so Mount Vernon officials hope free surveillance cameras for residents will help the city's public safety ...

by KOMO News Staff TOPICS: MOUNT VERNON, Wash. — An 18-year-old man is dead after a shooting at a Mount Vernon Chevron station late Monday night. Officers said they were dispatched to a report ...

AstraZeneca will leverage Alteogen’s platform technology to develop the therapies. Credit: © AstraZeneca 2025. AstraZeneca has entered an exclusive licence ...

Image credit: Kateryna Kon / Shutterstock. UK-based AstraZeneca’s acquired rare disease drug has met the primary endpoint in a Phase III trial in patients with chronic hypoparathyroidism. The Calypso ...